Post

MHRA revokes Novartis’ Adakveo authorisation for sickle cell disease

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has revoked a conditional marketing authorisation for Novartis Pharmaceuticals' Adakveo 10mg/ml …

Ono Pharmaceutical partners with EME for antibody drug discovery

Ono Pharmaceutical has entered a partnership with Epsilon Molecular Engineering (EME) to advance the drug discovery of the variable heavy …

Telehealth abortion is an “effective, safe” tool for equitable healthcare – US study

A large study about telehealth abortion conducted in the US has concluded that it is “effective, safe and comparable to …

Charles River and Wheeler Bio partner on therapeutic discovery

Charles River Laboratories has entered a strategic partnership with Wheeler Bio to expedite the progression from therapeutic discovery to manufacturing …

FDA accepts Regeneron’s BLA for linvoseltamab for review

The US Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ biologics licence application (BLA) for linvoseltamab to treat multiple …